Our use of cookies

We use necessary cookies to make our site work.

For more detailed information about the cookies we use, see our Cookie Policy.


Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Products in the UK

At Otsuka UK, we are dedicated to making a difference for patients in their daily lives. Below is a list of our medicines that are currently available in the UK. For each product below, you can find links to webpages where you can access the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SPC) for Great Britain (GB) and Northern Ireland (NI). Please note that this information is specific to the UK and is not intended to replace the advice of a qualified doctor.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects you can help provide more information on the safety of this medicine. For medicines with a black triangle: ▼ means the medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See https://yellowcard.mhra.gov.uk/ for how to report side effects.

Otsuka medication currently available in the UK

Medication Name GB Summary of Product Characteristics (SPC) Link GB Patient Information Leaflet (PIL) Link NI Summary of Product Characteristics (SPC) Link NI Patient Information Leaflet (PIL) Link
Samsca® (tolvaptan) SPC PIL SPC PIL
Jinarc®▼(tolvaptan) SPC PIL SPC PIL
Abilify Maintena® (aripiprazole) SPC PIL SPC PIL
Abilify® (aripiprazole) - Oral Solution SPC PIL SPC PIL
-Orodispersible Tablets SPC PIL SPC PIL
- Tablets SPC PIL SPC PIL
- Solution for Injection SPC PIL SPC  PIL
Lupkynis®▼(voclosporin) SPC PIL SPC PIL

Date of preparation: April 2023 | Reference: UK-NPR-2300017

Date of preparation: August 2023 | Reference UK-NPR-2300037

Copyright © 2021 Otsuka Pharmaceuticals (U.K.) Ltd. All rights reserved.
Registered in England and Wales with company no. 03615891.
Registered office: 2 Windsor Dials, Arthur Road, Windsor, Berkshire, SL4 1RS

This website is for all those with an interest in Otsuka Pharmaceuticals (U.K.) Ltd.